Company profile: DePuy Synthes
1.1 - Company Overview
Company description
- Provider of orthopedic and medtech equipment supporting healing and restoring movement. Offerings span joint reconstruction, trauma, craniomaxillofacial, spinal surgery, and sports medicine, plus ASC capabilities, advanced case management, loaner programs, matrixrib care, and orthopaedic education through the Johnson & Johnson Institute.
Products and services
- Trauma: DePuy Synthes delivers clinical-grade devices and systems to support healing of fractures and traumatic injuries, including MatrixRIB care and advanced case management
- Joint Reconstruction: The company architects surgical-grade products that restore movement and function for patients with joint issues, supported by ASC capabilities and loaner programs
- Spinal Surgery: The company develops hospital-grade products aimed at treating various spinal disorders and injuries, complemented by ASC capabilities and advanced case management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DePuy Synthes
Progressive Orthopaedics
HQ: United States
Website
- Description: Provider of high-quality stable technology implants to improve health outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Progressive Orthopaedics company profile →
AlterG
HQ: United States
Website
- Description: Provider of Anti-Gravity Treadmill solutions using NASA Differential Air Pressure technology for physical therapy and training, enabling reduced load and pain-free rehab. Offerings include FIT, VIA, and PRO models with data-driven rehab, session reports, live video monitoring, touchscreen interfaces, gait analytics, and elite athlete recovery; plus Lifeward services and clinical training videos.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AlterG company profile →
Synoste
HQ: Finland
Website
- Description: Provider of novel, patient-friendly medical solutions for treating skeletal deformities, initially focused on developing a better device for the complication-prone, uncomfortable limb lengthening procedure. Finnish startup utilizing smart materials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synoste company profile →
Osteotech
HQ: United States
Website
- Description: Provider of biologic, biomaterial, and device systems for musculoskeletal surgeries, facilitating spinal, trauma, and total joint revision procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Osteotech company profile →
Amend Surgical
HQ: United States
Website
- Description: Provider of natural and synthetic bone graft substitutes and orthobiologic solutions to enhance bone healing. Portfolio includes NanoFUSE Bioactive Matrix, a bone void filler combining bioactive glass and demineralized allograft for orthopedic and spinal fusion; Amend Tissue Tape, a non-resorbable hydrogel surgical glue for protecting oral wounds; and Tissure, a degradable hydrogel/chitosan adhesive for suture-less nerve repair to reconnect peripheral nerves.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amend Surgical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DePuy Synthes
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DePuy Synthes
2.2 - Growth funds investing in similar companies to DePuy Synthes
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DePuy Synthes
4.2 - Public trading comparable groups for DePuy Synthes
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →